EPO grants second CRISPR patent to ERS Genomics

07-03-2018

EPO grants second CRISPR patent to ERS Genomics

Natali_Mis / iStockphoto.com

The European Patent Office (EPO) has granted a second CRISPR/Cas9 patent to a specialist genomics company, one month after revoking the Broad Institute of Harvard and MIT’s patent relating to the technology.


Emmanuelle Charpentier, European Patent Office, CRISPR-Cas9 patent, genomics research, gene technology

LSIPR